HEREDITARY STUDIES ON THE FAMILIAR INNER EAR DEAFNESS

Inner ear cell therapy targeting hereditary deafness by activation of stem cell homing factors

Congenital deafness affects about 1 in 1000 children and more than half of them have a genetic background such as Connexin26 (CX26) gene mutation. Inner ear cell therapy for sensorineural hearing loss has been expected to be an effective therapy for hereditary deafness. Previously, we developed a novel strategy for inner ear cell therapy using bone marrow mesenchymal stem cells as a supplement ...

Splicing in the Inner Ear: a Familiar Tune, but What Are the Instruments?

Howard Hughes Medical Institute influx and a furtherdepolarization that opens thecalcium University of California, Los Angeles activated potassium channel. The opening of this chanLos Angeles, California 90095-1662 nel allows a K efflux from the cell, repolarizing the membrane. The timing of these Ca activated K channels determines the rate at which a stimulated cell can cSlo Splicing: A Theme ...

Hereditary Deafness Newsletter

Hereditary Deafness Newsletter

Hereditary Deafness Newsletter